{
    "condition": "Depression",
    "description": "Overview of treatment options for Depression.",
    "subclasses": [
        {
            "name": "Pharmacotherapy",
            "description": "Detailed information about Pharmacotherapy treatments for Depression.",
            "guidelines": [
                {
                    "level": "First Line",
                    "drugs": [
                        {
                            "name": "Citalopram",
                            "Drug Class": "SSRI",
                            "Dose": "20-40 mg",
                            "LOE": 1,
                            "Fatigue": 2.0,
                            "Cognitive Dysfunction": 2.0,
                            "Acceptability": 1.0,
                            "Drug Interactions": 1.0,
                            "Sedation": 1.0,
                            "Sexual Dysfunction": -1.0,
                            "Notes": "Monitor QTc",
                            "url": "https://www.uptodate.com/contents/citalopram-drug-information"
                        },
                        {
                            "name": "Escitalopram",
                            "Drug Class": "SSRI",
                            "Dose": "10-20 mg",
                            "LOE": 1,
                            "Fatigue": 2.0,
                            "Cognitive Dysfunction": 2.0,
                            "Efficacy": 1.0,
                            "Acceptability": 1.0,
                            "Drug Interactions": 1.0,
                            "Sedation": 1.0,
                            "Weight Gain": 1.0,
                            "Sexual Dysfunction": -1.0,
                            "Other Tolerability": 1.0,
                            "url":"https://www.uptodate.com/contents/escitalopram-drug-information"
                        },
                        {
                            "name": "Fluoxetine",
                            "Drug Class": "SSRI",
                            "Dose": "20-60 mg",
                            "LOE": 1,
                            "Fatigue": 2.0,
                            "Cognitive Dysfunction": 2.0,
                            "Acceptability": 1.0,
                            "Drug Interactions": -1.0,
                            "Discontinuation Syndrome": 1.0,
                            "Sedation": 1.0,
                            "Weight Gain": 1.0,
                            "Sexual Dysfunction": -1.0,
                            "Other Tolerability": 1.0,
                            "url":"https://www.uptodate.com/contents/fluoxetine-drug-information"
                        },
                        {
                            "name": "Fluvoxamine",
                            "Drug Class": "SSRI",
                            "Dose": "100-300 mg",
                            "LOE": 1,
                            "Fatigue": 2.0,
                            "Cognitive Dysfunction": 2.0,
                            "Drug Interactions": -1.0,
                            "Sedation": 1.0,
                            "Weight Gain": 1.0,
                            "Sexual Dysfunction": -1.0,
                            "url":"https://www.uptodate.com/contents/fluvoxamine-drug-information"
                        },
                        {
                            "name": "Paroxetine",
                            "Drug Class": "SSRI",
                            "Dose": "20-50 mg",
                            "LOE": 1,
                            "Fatigue": 2.0,
                            "Cognitive Dysfunction": 2.0,
                            "Efficacy": 1.0,
                            "Drug Interactions": -1.0,
                            "Discontinuation Syndrome": -1.0,
                            "Weight Gain": -1.0,
                            "Sexual Dysfunction": -1.0,
                            "url":"https://www.uptodate.com/contents/paroxetine-drug-information"
                        },
                        {
                            "name": "Sertraline",
                            "Drug Class": "SSRI",
                            "Dose": "50-200 mg",
                            "LOE": 1,
                            "Fatigue": 2.0,
                            "Cognitive Dysfunction": 2.0,
                            "Efficacy": 1.0,
                            "Acceptability": 1.0,
                            "Sedation": 1.0,
                            "Other Tolerability": 1.0,
                            "url": "https://www.uptodate.com/contents/sertraline-drug-information"
                        },
                        {
                            "name": "Desvenlafaxine",
                            "Drug Class": "SNRI",
                            "Dose": "50-100 mg",
                            "LOE": 1,
                            "Pain": 2.0,
                            "Drug Interactions": 1.0,
                            "Sedation": 1.0,
                            "Weight Gain": 1.0,
                            "Sexual Dysfunction": 1.0,
                            "Other Tolerability": 1.0,
                            "url": "https://www.uptodate.com/contents/desvenlafaxine-drug-information"
                        },
                        {
                            "name": "Duloxetine",
                            "Drug Class": "SNRI",
                            "Dose": "60-120 mg",
                            "LOE": 1,
                            "Pain": 1.0,
                            "Fatigue": 2.0,
                            "Cognitive Dysfunction": 2.0,
                            "Sedation": 1.0,
                            "Sexual Dysfunction": -1.0,
                            "url": "https://www.uptodate.com/contents/duloxetine-drug-information"
                        },
                        {
                            "name": "Levomilnacipran",
                            "Drug Class": "SNRI",
                            "Dose": "40-120 mg",
                            "LOE": 1,
                            "Pain": 2.0,
                            "Drug Interactions": 1.0,
                            "Sedation": 1.0,
                            "Weight Gain": 1.0,
                            "Notes": "Not Available in Canada",
                            "url":"https://www.uptodate.com/contents/levomilnacipran-drug-information"
                        },
                        {
                            "name": "Venlafaxine-XR",
                            "Drug Class": "SNRI",
                            "Dose": "75-225 mg",
                            "LOE": 1,
                            "Pain": 2.0,
                            "Efficacy": 1.0,
                            "Discontinuation Syndrome": -1.0,
                            "Sedation": 1.0,
                            "Sexual Dysfunction": -1.0,
                            "Other Tolerability": -1.0,
                            "url":"https://www.uptodate.com/contents/venlafaxine-drug-information"
                        },
                        {
                            "name": "Bupropion",
                            "Drug Class": "NDRI",
                            "Dose": "150-450 mg",
                            "LOE": 1,
                            "Fatigue": 1.0,
                            "Cognitive Dysfunction": 2.0,
                            "Efficacy": 1.0,
                            "Discontinuation Syndrome": 1.0,
                            "Sedation": 1.0,
                            "Weight Gain": 1.0,
                            "Sexual Dysfunction": 1.0,
                            "Other Tolerability": 1.0,
                            "url":"https://www.uptodate.com/contents/bupropion-drug-information"
                        },
                        {
                            "name": "Mirtazapine",
                            "Drug Class": "\u03b12 antagonist; 5-HT2 antagonist",
                            "Dose": "30-60 mg",
                            "LOE": 1,
                            "Sleep": 2.0,
                            "Efficacy": 1.0,
                            "Acceptability": 1.0,
                            "Drug Interactions": 1.0,
                            "Discontinuation Syndrome": 1.0,
                            "Sedation": -1.0,
                            "Weight Gain": -1.0,
                            "Sexual Dysfunction": 1.0,
                            "url":"https://www.uptodate.com/contents/mirtazapine-drug-information"
                        },
                        {
                            "name": "Vilazodone",
                            "Drug Class": "SRI; 5-HT1A agonist",
                            "Dose": "20-40 mg",
                            "LOE": 1,
                            "Drug Interactions": 1.0,
                            "Sedation": 1.0,
                            "Weight Gain": 1.0,
                            "Sexual Dysfunction": 1.0,
                            "Other Tolerability": 1.0,
                            "url":"https://www.uptodate.com/contents/vilazodone-drug-information"
                        },
                        {
                            "name": "Vortioxetine",
                            "Drug Class": "SRI; 5-HT1A, 5-HT1B agonist; 5-HT1D,\n5-HT3A, 5-HT7 antagonist",
                            "Dose": "10-20 mg",
                            "LOE": 1,
                            "Cognitive Dysfunction": 1.0,
                            "Efficacy": 1.0,
                            "Acceptability": 1.0,
                            "Drug Interactions": 1.0,
                            "Discontinuation Syndrome": 1.0,
                            "Sedation": 1.0,
                            "Weight Gain": 1.0,
                            "Sexual Dysfunction": 1.0,
                            "url":"https://www.uptodate.com/contents/vortioxetine-drug-information"
                        },
                        {
                            "name": "Agomelatine",
                            "Drug Class": "MT1, MT2 agonist; \n5-HT2 antagonist",
                            "Dose": "25-50 mg",
                            "LOE": 1,
                            "Sleep": 1.0,
                            "Efficacy": 1.0,
                            "Acceptability": 1.0,
                            "Drug Interactions": 1.0,
                            "Weight Gain": 1.0,
                            "Sexual Dysfunction": 1.0,
                            "Other Tolerability": 1.0,
                            "Notes": "Not Available in Canada; Monitor LFTs",
                            "url": "https://www.uptodate.com/contents/agomelatine-drug-information"
                        },
                        {
                            "name": "Mianserin",
                            "Drug Class": "\u03b12 antagonist; 5-HT2 antagonist",
                            "Dose": "30-90 mg",
                            "LOE": 1,
                            "Drug Interactions": 1.0,
                            "Sedation": -1.0,
                            "Other Tolerability": 1.0,
                            "Notes": "Not Available in Canada",
                            "url": "https://www.uptodate.com/contents/mianserin-drug-information"
                        },
                        {
                            "name": "Milnacipran",
                            "Drug Class": "SNRI",
                            "Dose": "30-90 mg",
                            "LOE": 1,
                            "Drug Interactions": 1.0,
                            "Sedation": 1.0,
                            "Notes": "Not Available in Canada",
                            "url":"https://www.uptodate.com/contents/milnacipran-drug-information"
                        }
                    ]
                },
                {
                    "level": "Second Line",
                    "drugs": [
                        {
                            "name": "Amitryptyline",
                            "Drug Class": "TCA",
                            "Dose": "75-300 mg",
                            "LOE": 1
                        },
                        {
                            "name": "Clomipramine",
                            "Drug Class": "TCA",
                            "Dose": "150-300 mg",
                            "LOE": 1
                        },
                        {
                            "name": "Desipramine",
                            "Drug Class": "TCA",
                            "Dose": "100-300 mg",
                            "LOE": 1
                        },
                        {
                            "name": "Doxepin",
                            "Drug Class": "TCA",
                            "Dose": "75-300 mg",
                            "LOE": 1
                        },
                        {
                            "name": "Imipramine",
                            "Drug Class": "TCA",
                            "Dose": "75-300 mg",
                            "LOE": 1
                        },
                        {
                            "name": "Nortryptyline",
                            "Drug Class": "TCA",
                            "Dose": "75-150 mg",
                            "LOE": 1
                        },
                        {
                            "name": "Protriptyline",
                            "Drug Class": "TCA",
                            "Dose": "30-60 mg",
                            "LOE": 1
                        },
                        {
                            "name": "Trimipramine",
                            "Drug Class": "TCA",
                            "Dose": "75-300 mg",
                            "LOE": 1
                        },
                        {
                            "name": "Moclobemide",
                            "Drug Class": "RIMA",
                            "Dose": "150-450 mg",
                            "LOE": 1
                        },
                        {
                            "name": "Trazodone",
                            "Drug Class": "SRI; 5-HT2 antagonist",
                            "Dose": "150-400 mg",
                            "LOE": 1,
                            "Sleep": 2.0
                        },
                        {
                            "name": "Quetiapine",
                            "Drug Class": "DA, 5-HT, \u03b11 & \u03b12 antagonist; NRI",
                            "Dose": "150-300 mg",
                            "LOE": 1,
                            "Sleep": 2.0
                        },
                        {
                            "name": "Dextromethorphan-Bupropion",
                            "Drug Class": "NMDA antagonist; NDRI, sigma-1 agonist",
                            "Dose": "45/105-90/210 mg",
                            "LOE": 2,
                            "Notes": "Not Available in Canada"
                        },
                        {
                            "name": "Nefazodone",
                            "Drug Class": "SRI, 5-HT2 antagonist",
                            "Dose": "300-600 mg",
                            "LOE": 1,
                            "Notes": "Not Available in Canada"
                        },
                        {
                            "name": "Selegiline transdermal",
                            "Drug Class": "MAO-B inhibitor",
                            "Dose": "6-12 mg",
                            "LOE": 2,
                            "Notes": "Not Available in Canada"
                        }
                    ]
                },
                {
                    "level": "Third Line",
                    "drugs": [
                        {
                            "name": "Phenelzine",
                            "Drug Class": "MAO inhibitor",
                            "Dose": "45-90 mg",
                            "LOE": 1
                        },
                        {
                            "name": "Tranylcypromine",
                            "Drug Class": "MAO inhibitor",
                            "Dose": "30-60 mg",
                            "LOE": 1
                        },
                        {
                            "name": "Reboxetine",
                            "Drug Class": "NRI",
                            "Dose": "8-12 mg",
                            "LOE": 1,
                            "Notes": "Not Available in Canada"
                        }
                    ]
                }
            ]
        },
        {
            "name": "Adjunct Pharmacotherapy",
            "description": "Detailed information about Adjunct Pharmacotherapy treatments for Depression.",
            "guidelines": [
                {
                    "level": "First Line",
                    "drugs": [
                        {
                            "name": "Aripiprazole",
                            "Dose": "2-10 mg",
                            "LOE": 1.0
                        },
                        {
                            "name": "Brexpiprazile",
                            "Dose": "0.5-2 mg",
                            "LOE": 1.0
                        }
                    ]
                },
                {
                    "level": "Second Line",
                    "drugs": [
                        {
                            "name": "Bupropion",
                            "Dose": "150-450 mg",
                            "LOE": 1.0
                        },
                        {
                            "name": "Intranasal esketamine",
                            "Dose": "56-84 mg",
                            "LOE": 1.0
                        },
                        {
                            "name": "IV racemic ketamine",
                            "Dose": "0.5-1.0 mg/kg",
                            "LOE": 1.0
                        },
                        {
                            "name": "Olanzapine",
                            "Dose": "2.5-10 mg",
                            "LOE": 1.0
                        },
                        {
                            "name": "Quetiapine-XR",
                            "Dose": "150-300 mg",
                            "LOE": 1.0
                        },
                        {
                            "name": "Risperidone",
                            "Dose": "1-3 mg",
                            "LOE": 1.0
                        },
                        {
                            "name": "Lithium",
                            "Dose": "600-1200 mg (0.5-0.8 mmol/L)",
                            "LOE": 1.0
                        },
                        {
                            "name": "Cariprazine",
                            "Dose": "1.5-3 mg",
                            "LOE": 2.0
                        },
                        {
                            "name": "Mirtazapine",
                            "Dose": "30-60 mg",
                            "LOE": 2.0
                        },
                        {
                            "name": "Mianserin",
                            "Dose": "30-90 mg",
                            "LOE": 2.0
                        },
                        {
                            "name": "Modafinil",
                            "Dose": "100-400 mg",
                            "LOE": 2.0
                        },
                        {
                            "name": "Triiodothyronine",
                            "Dose": "25-50 mcg",
                            "LOE": 2.0
                        }
                    ]
                },
                {
                    "level": "Third Line",
                    "drugs": [
                        {
                            "name": "Other antidepressants including TCA",
                            "LOE": 3.0
                        },
                        {
                            "name": "Stimulants",
                            "LOE": 3.0
                        },
                        {
                            "name": "Lamotrigine",
                            "Dose": "100-300 mg",
                            "LOE": 3.0
                        },
                        {
                            "name": "Non-IV racemic ketamine",
                            "LOE": 3.0
                        },
                        {
                            "name": "Pramipexole",
                            "Dose": "1-2 mg BID",
                            "LOE": 3.0
                        },
                        {
                            "name": "Ziprasidone",
                            "Dose": "20-80 mg BID",
                            "LOE": 3.0
                        }
                    ]
                },
                {
                    "level": "Investigational",
                    "drugs": [
                        {
                            "name": "Psychedelic-assisted psychotherapy",
                            "LOE": 3.0
                        }
                    ]
                },
                {
                    "level": "Not Recommended",
                    "drugs": [
                        {
                            "name": "Cannabis"
                        }
                    ]
                }
            ]
        },
        {
            "name": "Psychotherapy",
            "description": "Detailed information about Psychotherapy treatments for Depression.",
            "guidelines": [
                {
                    "level": "First Line",
                    "drugs": [
                        {
                            "name": "Cognitive-Behavioural Therapy (CBT)",
                            "LOE": 1
                        },
                        {
                            "name": "Interpersonal Therapy (IPT)",
                            "LOE": 1
                        },
                        {
                            "name": "Behavioural Activation (BA)",
                            "LOE": 1
                        }
                    ]
                },
                {
                    "level": "Second Line",
                    "drugs": [
                        {
                            "name": "Cognitive Behavioural Analysis System of Psychotherapy (CBASP)",
                            "LOE": 2
                        },
                        {
                            "name": "Mindfulness-Based Cognitive Therapy (MBCT)",
                            "LOE": 2
                        },
                        {
                            "name": "Problem-Solving Therapy (PST)",
                            "LOE": 2
                        },
                        {
                            "name": "Short-term Psychodynamic Psychotherapy (STPP)",
                            "LOE": 2
                        },
                        {
                            "name": "Transdiagnostic Psychological Treatment of Emotional Disorders",
                            "LOE": 2
                        }
                    ]
                },
                {
                    "level": "Third Line",
                    "drugs": [
                        {
                            "name": "Acceptance & Commitment Therapy (ACT)",
                            "LOE": 3
                        },
                        {
                            "name": "Long-term Psychodynamic Psychotherapy (PDT)",
                            "LOE": 3
                        },
                        {
                            "name": "Metacognitive Therapy (MCT)",
                            "LOE": 3
                        },
                        {
                            "name": "Motivational Interviewing",
                            "LOE": 4
                        }
                    ]
                }
            ]
        },
        {
            "name": "Lifestyle",
            "description": "Detailed information about Lifestyle treatments for Depression.",
            "guidelines": [
                {
                    "level": "First Line",
                    "drugs": [
                        {
                            "name": "Supervised Exercise",
                            "Indication": "Mild MDE",
                            "Details": "Low-Moderate Intensity, 3-4/week, minimum 9 weeks",
                            "LOE": 1.0
                        },
                        {
                            "name": "Light Therapy",
                            "Indication": "Seasonal (Winter) MDE",
                            "Details": "10,000 lux for 30 min daily",
                            "LOE": 1.0
                        }
                    ]
                },
                {
                    "level": "Second Line",
                    "drugs": [
                        {
                            "name": "Light Therapy",
                            "Indication": "Mild MDE",
                            "LOE": 2.0
                        },
                        {
                            "name": "Adjunctive Exercise",
                            "Indication": "Moderate MDE",
                            "LOE": 2.0
                        },
                        {
                            "name": "Adjunctive Light Therapy",
                            "Indication": "Moderate MDE",
                            "LOE": 2.0
                        },
                        {
                            "name": "Adjunctive Sleep Hygiene & CBT-I",
                            "Details": "Varied diet with high content of fruit, vegetables, and fibre, and low content of saturated fat and carbohydrates",
                            "LOE": 3.0
                        }
                    ]
                },
                {
                    "level": "Third Line",
                    "drugs": [
                        {
                            "name": "Adjunctive Healthy Diet",
                            "LOE": 3.0
                        },
                        {
                            "name": "Adjunctive Mediterranean Diet",
                            "LOE": 3.0
                        },
                        {
                            "name": "Adjunctive Sleep Deprivation",
                            "LOE": 3.0
                        }
                    ]
                },
                {
                    "level": "Insufficient Evidence",
                    "drugs": [
                        {
                            "name": "Probiotics"
                        }
                    ]
                }
            ]
        },
        {
            "name": "Digital Health Intervention",
            "description": "Detailed information about Digital Health Intervention treatments for Depression.",
            "guidelines": [
                {
                    "level": "Guided",
                    "drugs": [
                        {
                            "name": "Good Days Ahead",
                            "Rct": "Yes",
                            "Description": "Program designed for use by a CBT therapist to provide \nadditional CBT instruction outside of the session.",
                            "Comments": "Two large RCTs showed this program reduced the need \nfor face-to-face CBT by half, with equivalent clinical \noutcomes."
                        },
                        {
                            "name": "BounceBack",
                            "Description": "Free online CBT program with various formats: \nself-directed version, or with telephone-delivered lay \ncoaching.",
                            "Comments": "No RCT but a large prospective study was positive in \nMDD; available free in several Canadian provinces, \nmanaged by the Canadian Mental Health Association"
                        },
                        {
                            "name": "Deprexis",
                            "Rct": "Yes",
                            "Notes": "Not Available in Canada",
                            "Description": "Online CBT program with tailored guidance provided by an \nAI conversational agent; includes BA and mindfulness \ntechniques.",
                            "Comments": "Structured 12-week program designed for 90-day use; \navailable in many countries in several languages; tested \nin multiple clinical trials, with a positive meta-analysis. \nAvailable in Europe and the USA."
                        },
                        {
                            "name": "MoodBeacon",
                            "Description": "Online guided CBT program; guidance provided by trained \ntherapists.",
                            "Comments": "Although there is no published study, this DHI was \nreviewed and approved for use by the Province of \nOntario in 2021."
                        },
                        {
                            "name": "Pacifica/Sanvello",
                            "Rct": "Yes",
                            "Notes": "Not Available in Canada",
                            "Description": "Mobile- and web-based apps intended to assist users in \nrelieving stress, anxiety, and depression. Free; offers \nin-app purchases",
                            "Comments": "Uses blend of CBT, mindfulness, and relaxation tools; \nsuitable for adults and adolescents; guidance is through \npeer discussion in chat groups; has positive results \nfrom an RCT. Available in the USA."
                        }
                    ]
                },
                {
                    "level": "Unguided",
                    "drugs": [
                        {
                            "name": "Catch It",
                            "Description": "Free CBT-based mobile app, primarily uses automatic \nthought records and reflection exercises to address \nanxiety and depressive symptoms.",
                            "Comments": "Developed jointly by the Universities of Liverpool and \nManchester; includes a mood tracker and diary; and \nhas an observational trial of users showing benefits."
                        },
                        {
                            "name": "Headspace",
                            "Description": "Popular mobile app with self-guided meditation and \nmindfulness techniques and some CBT approaches.",
                            "Comments": "Designed for a wide variety of stress, depression and \nanxiety symptoms; extensively studied with good \noutcomes in many conditions (of mild severity), but \nnot specifically in MDD."
                        },
                        {
                            "name": "MoodGYM",
                            "Rct": "Yes",
                            "Description": "Internet-based CBT self-help program, with very structured \nmodules.",
                            "Comments": "Most widely used platform; initially developed by \nAustralian National University; extensively studied \nwith good outcomes in mild depression."
                        },
                        {
                            "name": "MoodKit",
                            "Rct": "Yes",
                            "Notes": "Not Available in Canada",
                            "Description": "CBT-based toolkit app with detailed instructions on how to \nuse thought records and BA.",
                            "Comments": "Teaches multiple aspects of CBT and is well-integrated \nwith mood monitoring and optional journaling. \nAvailable in the USA."
                        },
                        {
                            "name": "Spark Direct",
                            "Rct": "Yes",
                            "Notes": "Not Available in Canada",
                            "Description": "A mobile app providing core elements of CBT and BA in a \n5-week program.",
                            "Comments": "Designed for youth depression; uses interactive tasks and \nrewards; tested in an RCTwith positive findings. \nAvailable in the USA."
                        }
                    ]
                }
            ]
        },
        {
            "name": "Complementary & Alternative",
            "description": "Detailed information about Complementary & Alternative treatments for Depression.",
            "guidelines": [
                {
                    "level": "First Line",
                    "drugs": [
                        {
                            "name": "St. John's Wort",
                            "Indication": "Mild MDE",
                            "LOE": 1
                        }
                    ]
                },
                {
                    "level": "Second Line",
                    "drugs": [
                        {
                            "name": "Acupuncture",
                            "Indication": "Mild MDE",
                            "LOE": 2
                        },
                        {
                            "name": "St. John's Wort",
                            "Indication": "Moderate MDE",
                            "LOE": 2
                        },
                        {
                            "name": "Adjunctive Acupuncture",
                            "Indication": "Moderate MDE",
                            "LOE": 2
                        },
                        {
                            "name": "Adjunctive L-methyl folate",
                            "Indication": "Mild-Moderate MDE",
                            "LOE": 2
                        }
                    ]
                },
                {
                    "level": "Third Line",
                    "drugs": [
                        {
                            "name": "Adjunctive SAM-e",
                            "Indication": "Mild-Moderate MDE",
                            "LOE": 2
                        },
                        {
                            "name": "DHEA",
                            "Indication": "Mild MDE",
                            "LOE": 3
                        },
                        {
                            "name": "Omega-3 Fatty Acids",
                            "Indication": "Mild MDE",
                            "LOE": 3
                        },
                        {
                            "name": "Saffron, Lavendar, or Roseroot",
                            "Indication": "Mild MDE",
                            "LOE": 3
                        }
                    ]
                }
            ]
        },
        {
            "name": "Neuromodulation",
            "description": "Detailed information about Neuromodulation treatments for Depression.",
            "guidelines": [
                {
                    "level": "First Line",
                    "drugs": [
                        {
                            "name": "ECT",
                            "Indication": "Severe MDE",
                            "Acute LOE": 1,
                            "Maintenance LOE": 1
                        },
                        {
                            "name": "rTMS",
                            "Indication": "TRD",
                            "Acute LOE": 1,
                            "Maintenance LOE": 3
                        }
                    ]
                },
                {
                    "level": "Second Line",
                    "drugs": [
                        {
                            "name": "ECT",
                            "Indication": "DTD",
                            "Acute LOE": 1,
                            "Maintenance LOE": 3
                        }
                    ]
                },
                {
                    "level": "Third Line",
                    "drugs": [
                        {
                            "name": "Adjunctive tDCS",
                            "Indication": "Mild-Moderate MDE",
                            "Acute LOE": 2,
                            "Maintenance LOE": 3
                        },
                        {
                            "name": "VNS",
                            "Indication": "DTD",
                            "Acute LOE": 3,
                            "Maintenance LOE": 3
                        }
                    ]
                },
                {
                    "level": "Investigational",
                    "drugs": [
                        {
                            "name": "DBS",
                            "Indication": "DTD",
                            "Acute LOE": 3,
                            "Maintenance LOE": "-"
                        },
                        {
                            "name": "MST",
                            "Indication": "DTD",
                            "Acute LOE": 3,
                            "Maintenance LOE": "-"
                        }
                    ]
                }
            ]
        }
    ]
}